Skip to main content
Clinical Trials/NCT05210322
NCT05210322
Active, not recruiting
Not Applicable

The Percutaneous Cholangiopancreatoscopy Registry

Johns Hopkins University1 site in 1 country679 target enrollmentJanuary 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Biliary Stones
Sponsor
Johns Hopkins University
Enrollment
679
Locations
1
Primary Endpoint
Tube free survival
Status
Active, not recruiting
Last Updated
3 months ago

Overview

Brief Summary

The Percutaneous Cholangiopancreatoscopy (PCPS) registry is an observational, multicentric, prospective, and retrospective registry of patients undergoing the percutaneous cholangiopancreatoscopy procedure at sites across the United States. In the retrospective component of the study, clinical and procedural data regarding patients who have undergone clinical indicated percutaneous cholangiopancreatoscopy procedure in the past will be collected from all the registry sites and stored in a secure database. The prospective component of the registry will run for three years at each site where patients undergoing the clinically indicated percutaneous cholangiopancreatoscopy procedure will be enrolled in the study, and the patients' data will be collected whenever the patients present to interventional radiology (IR) for a procedure or clinic visit.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
June 30, 2027
Last Updated
3 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female adults
  • 18 years of age and older
  • Patients undergoing clinically indicated percutaneous cholangiopancreatoscopy procedure at the Johns Hopkins Hospital or one of the registry sites.
  • Willing and able to understand and sign a written informed consent document for the prospective component of the study.

Exclusion Criteria

  • Pregnant women
  • Children (\< 18 years of age)

Outcomes

Primary Outcomes

Tube free survival

Time Frame: Up to 3 years

Tube free survival will be calculated by estimating the number of patients who can undergo removal of the biliary/ cholecystostomy tube after the PCPS procedure until their last IR clinical follow-up or death.

Secondary Outcomes

  • Complication rate(1 month)
  • Procedural success(At the time of the procedure)
  • Technical success(At the time of the procedure)
  • Clinical success(At the time of the procedure)
  • Complication rate(At the time of the procedure)

Study Sites (1)

Loading locations...

Similar Trials